Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes

Chemico-Biological Interactions

Volumn 164, Issue 1-2, 2006, Pages 136-145

  Hanioka, Nobumitsu ^a   Takeda, Yuri ^a   Jinno, Hideto ^b   Tanaka Kagawa, Toshiko ^b   Naito, Shinsaku ^c   Koeda, Akiko ^d   Shimizu, Takefumi ^d   Nomura, Mamoru ^d   Narimatsu, Shizuo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^d N   (Japan)

Author keywords

4 Methylumbelliferone (4 MU); Cynomolgus monkey; Human; Primates; Serotonin (5 HT); UDP glucuronosyltransferase (UGT); UGT1A6

Indexed keywords

ENZYME; HYMECROMONE; SEROTONIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A6;

ADULT; AGED; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME KINETICS; FEMALE; GLUCURONIDATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MICROSOME; MOLECULAR CLONING; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; YEAST CELL;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA, COMPLEMENTARY; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; HYMECROMONE; KINETICS; MACACA FASCICULARIS; MICROSOMES; MICROSOMES, LIVER; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SEROTONIN; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; XENOBIOTICS;

MACACA FASCICULARIS; PRIMATES;

EID: 33750739231     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.09.006     Document Type: Article

References (33)

1. Dutton G.J. Glucuronidation of Drugs and other Compounds (1980), CRC Press, Boca Raton, FL
2. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Bélanger A., Fournel-Gigleux S., Green M., Hum D.W., Iyanagi T., Lancet D., Louisot P., Magdalou J., Chowdhury J.R., Ritter J.K., Schachter H., Tephly T.R., Tipton K.F., and Nebert D.W. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7 (1997) 255-269
3. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 581-616
4. Burchell B., Brierley C.H., Monaghan G., and Clarke D.J. The structure and function of the UDP-glucuronosyltransferase gene family. Adv. Pharmacol. 42 (1998) 335-338
5. Ritter J.K., Chen F., Sheen Y.Y., Tran H.M., Kimura S., Yeatman M.T., and Owens I.S. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J. Biol. Chem. 267 (1992) 3257-3261
6. Monaghan G., Clarke D.J., Povey S., See C.G., Boxer M., and Burchell B. Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13. Genomics 23 (1994) 496-499
7. Radominska-Pandya A., Czernik P.J., Little J.M., Battaglia E., and Mackenzie P.I. Structural and functional studies of UDP-glucuronosyltransferases. Drug. Metab. Rev. 31 (1999) 817-899
8. King C.D., Rios G.R., Assouline J.A., and Tephly T.R. Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate. Arch. Biochem. Biophys. 365 (1999) 156-162
9. Krishnaswamy S., Duan S.X., von Moltke L.L., Greenblatt D.J., and Court M.H. Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6. Drug Metab. Dispos. 31 (2003) 133-139
10. Ritter J.K. Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem. Biol. Interact. 129 (2000) 171-193
11. Mackenzie P.I., Bock K.W., Burchell B., Guillemette C., Ikushiro S., Iyanagi T., Miners J.O., Owens I.S., and Nebert D.W. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genom. 15 (2005) 677-685
12. Romanos M.A., Scorer C.A., and Clare J.J. Foreign gene expression in yeast: a review. Yeast 8 (1992) 423-488
13. Schiestl R.H., and Gietz R.D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16 (1989) 339-346
14. Oeda K., Sakaki T., and Ohkawa H. Expression of rat liver cytochrome P-450MC cDNA in Saccharomyces cerevisiae. DNA 4 (1985) 203-210
15. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
17. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354
18. Krishnaswamy S., Duan S.X., von Moltke L.L., Greenblatt D.J., Sudmeier J.L., Bachovchin W.W., and Court M.H. Serotonin (5-hydroxytryptamine) glucuronidation in vitro: assay development, human liver microsome activities and species differences. Xenobiotica 33 (2003) 169-180
19. Hanioka N., Jinno H., Tanaka-Kagawa T., Nishimura T., and Ando M. Determination of UDP-glucuronosyltransferase UGT1A6 activity in human and rat liver microsomes by HPLC with UV detection. J. Pharm. Biomed. Anal. 25 (2001) 65-75
20. Bock K.W., Gschaidmeier H., Heel H., Lehmköster T., Münzel P.A., Raschko F., and Bock-Hennig B.S. AH receptor-controlled transcriptional regulation and function of rat and human UDP-glucuronosyltransferase isoforms. Adv. Enzyme Regul. 38 (1998) 207-222
21. Bock K.W., Gschaidmeier H., Heel H., Lehmköster T., Münzel P.A., and Bock-Hennig B.S. Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases. Drug Metab. Rev. 31 (1999) 411-422
22. Krishnaswamy S., Hao Q., Al-Rohaimi A., Hesse L.M., von Moltke L.L., Greenblatt D.J., and Court M.H. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5′-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation. J. Pharmacol. Exp. Ther. 313 (2005) 1331-1339
23. Court M.H. Isoform-selective probe substrates for in vitro studies of human UDP- glucuronosyltransferases. Methods Enzymol. 400 (2005) 104-116
24. Krishnaswamy S., Hao Q., Al-Rohaimi A., Hesse L.M., von Moltke L.L., Greenblatt D.J., and Court M.H. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S). J. Pharmacol. Exp. Ther. 313 (2005) 1340-1346
25. Burchell B., Brierley C.H., and Rance D. Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci. 57 (1995) 1819-1831
26. Miners J.O., Lillywhite K.J., Matthews A.P., Jones M.E., and Birkett D.J. Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes. Biochem. Pharmacol. 37 (1988) 665-671
27. Uchaipichat V., Mackenzie P.I., Guo X.H., Gardner-Stephen D., Galetin A., Houston J.B., and Miners J.O. Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab. Dispos. 32 (2004) 413-423
28. Ciotti M., Marrone A., Potter C., and Owens I.S. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 7 (1997) 485-495
29. Nagar S., Zalatoris J.J., and Blanchard R.L. Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics 14 (2004) 487-499
30. Saeki M., Saito Y., Jinno H., Sai K., Kaniwa N., Ozawa S., Komamura K., Kotake T., Morishita H., Kamakura S., Kitakaze M., Tomoike H., Shirao K., Minami H., Ohtsu A., Yoshida T., Saijo N., Kamatani N., and Sawada J. Genetic polymorphisms of UGT1A6 in a Japanese population. Drug Metab. Pharmacokinet. 20 (2005) 85-90
31. Ouzzine M., Magdalou J., Burchell B., and Fournel-Gigleux S. An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyltransferase 1A6 to the endoplasmic reticulum. J. Biol. Chem. 274 (1999) 31401-31409
32. Köhle C., Möhrle B., Münzel P.A., Schwab M., Wernet D., Badary O.A., and Bock K.W. Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochem. Pharmacol. 65 (2003) 1521-1527
33. Peters W.H., te Morsche R.H., and Roelofs H.M. Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome. J. Hepatol. 38 (2003) 3-8